All articles tagged with #myeloma
Scientists have successfully engineered cancer-fighting T-cells inside patients' bodies for the first time, potentially making CAR T-cell therapy faster, cheaper, and more accessible for treating multiple myeloma, with promising early results and manageable side effects.
A groundbreaking 'Trojan horse' therapy, belantamab mafodotin, has been made available on the NHS in England for treating multiple myeloma, significantly extending remission times and offering a more targeted and less harmful treatment option, marking a major advancement in cancer care.
Eleanor Bailey, a 53-year-old fit and healthy woman, was shocked to discover she had myeloma, a rare blood cancer, after experiencing unexplained fractures and persistent pain. She is undergoing gruelling treatment including chemotherapy, stem-cell transplant, and monthly bone infusions. Despite the challenges, she remains hopeful and is grateful for the support from family and friends, but looks forward to the day when she can enjoy life's small joys again.
Scientists have developed a gene test that can identify the ten per cent of blood-cancer patients who see little effect from lenalidomide, a drug that can stop their cancer from returning. The test looks for genetic clues in cancer cells and can spare patients needless side effects such as exhaustion, infections, and a higher risk of other cancers. It also helps to spot patients who may need other medicines alongside lenalidomide and gives peace of mind to those most likely to benefit. The test is already widely available in the NHS and could be used to guide treatment for the 6,000 Britons diagnosed with myeloma each year.